In this episode, Medicom’s correspondent covers 4 presentations from annual meeting of the Dutch Dermatology Days (DDD 2025), held in Ugchelen, the Netherlands, from 10-11 April 2025.
The topics discussed are:
“The disease burden of atopic dermatitis is multidimensional,” said Dr Marlies de Graaf (University Medical Centre Utrecht, the Netherlands) at the beginning of her talk on the management of atopic dermatitis in children. “Beyond the burden of eczema lesions and symptoms, the condition affects school performance, mental health, family dynamics, sleep, and social life of these children.” In addition, comorbidities and skin infections are common in this population. The disease burden is also cumulative, starting with the symptoms of atopic dermatitis and progressively impacting other life aspects over time. So, where do we stand in 2025 in terms of treatment options? Dr de Graaf discussed the current landscape of managing atopic dermatitis in children.
VEXAS syndrome is a relatively newly discovered auto-inflammatory syndrome. Since skin manifestations are an early indicator of this disease, dermatologists play an important role in identifying patients with suspected VEXAS syndrome. Dr Joost Meijer (University Medical Centre Groningen, the Netherlands) shared key diagnostic insights and clues with the audience.
The diagnosis of vascular anomalies has been challenging for dermatologists. Fortunately, refined classification systems may help make an accurate diagnosis. In parallel, recent genetic research unravelled some of the underlying mechanisms of vascular anomalies, which allows the development of targeted management strategies for patients.
Misinformation is omnipresent, and medical professionals struggle to deal with the harmful effects that influencers and other sources of misinformation have on their patients. Understanding the psychological mechanisms behind misinformation can help us guide patients back toward evidence-based medicine.
Enjoy listening!
Copyright ©2025 Medicom Medical Publishers
Posted on
Previous Article
« Correlation between Life’s Essential 8 Scores and asthma risk Next Article
Validation of the CAD-Q questionnaire for COPD-asthma differentiation »
« Correlation between Life’s Essential 8 Scores and asthma risk Next Article
Validation of the CAD-Q questionnaire for COPD-asthma differentiation »
Table of Contents: DDD 2025
Featured articles
How to deal with misinformation in the medical world
Paediatric Dermatology
Management of atopic dermatitis in children in 2025
New horizon for classifying and managing vascular anomalies
What’s New?
Novel markers to monitor treatment response and progression in Sézary syndrome
Vitiligo and the risk for skin cancer
Crucial role of TFAP2a in skin health unravelled
Updates in Dermato-oncology
Emerging intralesional therapies for BCC
Diagnosis and management of atypical melanocytic lesions
Expanding treatment armamentarium for actinic keratosis and Bowen’s disease
Social Media and Dermatology
Guiding patients through the social media maze
How to deal with misinformation in the medical world
Auto-inflammatory Diseases
A guide to recognise and manage Schnitzler syndrome in clinical practice
VEXAS syndrome and its cutaneous manifestations
Related Articles
May 17, 2022
New insights into psoriasis comorbidity
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com